Development of guidelines on good manufacturing of biomedical cell products

The article presents the essence of draft of the Guidance of good manufacturing practices of biomedical cell products (BMCP) (GMP/GTP guideline) harmonized with the international requirements, which contains the basic quality and safety standards of clinical application of these products. These regu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: M. A. Tulina, N. V. Pyatigorskaya
Formato: article
Lenguaje:RU
Publicado: Scientific Сentre for Family Health and Human Reproduction Problems 2017
Materias:
Q
Acceso en línea:https://doaj.org/article/976656b1e49a427d9fb69723ad8f9be7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:976656b1e49a427d9fb69723ad8f9be7
record_format dspace
spelling oai:doaj.org-article:976656b1e49a427d9fb69723ad8f9be72021-11-23T06:14:37ZDevelopment of guidelines on good manufacturing of biomedical cell products2541-94202587-959610.12737/article_59f035fb9ec0d8.64599419https://doaj.org/article/976656b1e49a427d9fb69723ad8f9be72017-05-01T00:00:00Zhttps://www.actabiomedica.ru/jour/article/view/391https://doaj.org/toc/2541-9420https://doaj.org/toc/2587-9596The article presents the essence of draft of the Guidance of good manufacturing practices of biomedical cell products (BMCP) (GMP/GTP guideline) harmonized with the international requirements, which contains the basic quality and safety standards of clinical application of these products. These regulations prescribe the requirements for institutions engaged in one or more stages of BMCP production and allow to avoid any risk of contamination of cells, tissues and finished product. The aim of this work is to develop a methodology for BMCPs' quality assurance framework. Materials and methods. The main subjects of research are national and international laws and regulations, publications on quality assurance systems of cell products, problems of BMCP manufacturing and validation. Results. The draft Guidance of good manufacturing practices of BMCP (GMP/GTP guideline), including specific requirements to donor determination, biomaterial sampling and its transportation to the manufacture, to risk management system, traceability system, to processing, definition of minimally manipulated BMCP, requirements to incoming control, continuous in-process control and control of finished BMCP, to pharmacovigilance system were developed. Specific features of the manufacture of test products for non-clinical and clinical studies are described. Assessment elements for certification prior to release of each batch of test BMCP were clarified. Recommendations on the introduction of a product coding system according to ISBT 128 Standard are given in this work.M. A. TulinaN. V. PyatigorskayaScientific Сentre for Family Health and Human Reproduction Problemsarticlebiomedical cell productslegal regulationgood manufacturingquality management systempharmacovigilanceScienceQRUActa Biomedica Scientifica, Vol 2, Iss 3, Pp 58-62 (2017)
institution DOAJ
collection DOAJ
language RU
topic biomedical cell products
legal regulation
good manufacturing
quality management system
pharmacovigilance
Science
Q
spellingShingle biomedical cell products
legal regulation
good manufacturing
quality management system
pharmacovigilance
Science
Q
M. A. Tulina
N. V. Pyatigorskaya
Development of guidelines on good manufacturing of biomedical cell products
description The article presents the essence of draft of the Guidance of good manufacturing practices of biomedical cell products (BMCP) (GMP/GTP guideline) harmonized with the international requirements, which contains the basic quality and safety standards of clinical application of these products. These regulations prescribe the requirements for institutions engaged in one or more stages of BMCP production and allow to avoid any risk of contamination of cells, tissues and finished product. The aim of this work is to develop a methodology for BMCPs' quality assurance framework. Materials and methods. The main subjects of research are national and international laws and regulations, publications on quality assurance systems of cell products, problems of BMCP manufacturing and validation. Results. The draft Guidance of good manufacturing practices of BMCP (GMP/GTP guideline), including specific requirements to donor determination, biomaterial sampling and its transportation to the manufacture, to risk management system, traceability system, to processing, definition of minimally manipulated BMCP, requirements to incoming control, continuous in-process control and control of finished BMCP, to pharmacovigilance system were developed. Specific features of the manufacture of test products for non-clinical and clinical studies are described. Assessment elements for certification prior to release of each batch of test BMCP were clarified. Recommendations on the introduction of a product coding system according to ISBT 128 Standard are given in this work.
format article
author M. A. Tulina
N. V. Pyatigorskaya
author_facet M. A. Tulina
N. V. Pyatigorskaya
author_sort M. A. Tulina
title Development of guidelines on good manufacturing of biomedical cell products
title_short Development of guidelines on good manufacturing of biomedical cell products
title_full Development of guidelines on good manufacturing of biomedical cell products
title_fullStr Development of guidelines on good manufacturing of biomedical cell products
title_full_unstemmed Development of guidelines on good manufacturing of biomedical cell products
title_sort development of guidelines on good manufacturing of biomedical cell products
publisher Scientific Сentre for Family Health and Human Reproduction Problems
publishDate 2017
url https://doaj.org/article/976656b1e49a427d9fb69723ad8f9be7
work_keys_str_mv AT matulina developmentofguidelinesongoodmanufacturingofbiomedicalcellproducts
AT nvpyatigorskaya developmentofguidelinesongoodmanufacturingofbiomedicalcellproducts
_version_ 1718417022825529344